Medipal completes share buyback, announces cancellation and strategic acquisition

Medipal Holdings Corporation announced the completion of its treasury stock acquisition program, which ran from May 14, 2025, to October 31, 2025. The company acquired a total of 3,251,000 common shares for 7,999,832,693 yen, with 640,000 shares acquired in October 2025 for 1,625,075,690 yen. Following this, Medipal will cancel all 3,251,000 shares on November 28, 2025, representing 1.48% of its issued common stock before cancellation, reducing outstanding shares to 215,975,042.

This share buyback and cancellation align with the company's strategy to improve capital efficiency through shareholder returns, as resolved by the board of directors on May 13, 2025. Concurrently, Medipal's consolidated subsidiary, MP Agro Co., Ltd., will acquire 100% of Cygni Holdings, Inc. shares from BCM-V Investment Limited Partnership by December 19, 2025.

This strategic acquisition aims to expand Medipal's AGRO&FOOD sector by integrating Cygni Corporation's e-commerce business for veterinary clinics, strengthening its companion animal-related products and food processing raw materials businesses, and achieving synergies through broader market reach and online sales channels.